C-6-Cl-ddG is a pharmaceutical intermediate used in the synthesis of carbocyclic nucleosides. It is a chiral compound containing a purine ring system with a chlorine substituent and a cyclopentylmethanol group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing C-6-Cl-ddG?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride
pharmaceutical intermediate
2-thiouridine
pharmaceutical intermediate
3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid
pharmaceutical intermediate
2-Methoxy-3-nitropyridine
pharmaceutical intermediate
(1R,2S,3S,5R)-3-(6-Amino-9H-purin-9-yl)-4,4-difluoro-5-(hydroxymethyl)cyclopentane-1,2-diol
pharmaceutical intermediate
3-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
research compound
[(1R,3S)-3-(2-amino-6-chloropurin-9-yl)cyclopentyl]methanol
DOKOPGLGDNHBAS-RQJHMYQMSA-N
C1C[C@@H](C[C@@H]1CO)N2C=NC3=C2N=C(N=C3Cl)N
Sourcing C-6-Cl-ddG?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.